THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry. (23rd January 2014)
- Record Type:
- Journal Article
- Title:
- THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry. (23rd January 2014)
- Main Title:
- THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry
- Authors:
- Godot, S.
Gottenberg, J.E.
Paternotte, S.
Pane, I.
Combe, B.
Sibilia, J.
Flipo, R.-M.
Schaeverbeke, T.
Ravaud, P.
Toussirot, E.
Berenbaum, F.
Mariette, X.
Wendling, D.
Sellam, J. - Abstract:
- Abstract : Background: The risk of post-surgical complications related to the use of non anti-TNF biological agents in patients with rheumatoid arthritis (RA) remains unclear. The aim of this study was to investigate the safety of surgery in RA patients treated by rituximab (RTX) in routine care using data from the AutoImmunity and Rituximab (AIR) registry. Methods: The AIR registry has been set up by the French Society of Rheumatology and includes RA patients treated with RTX. The charts of patients undergoing any surgery during the year following an infusion of RTX were reviewed in order to i)describe the frequency of postsurgical complications, ii) to compare the characteristics of patients w/o complications and iii) to identify the parameters associated with postoperative side effects in a multivariate logistic regression analysis. Results: 1972 patients have been enrolled patients until August 2010. 133 patients underwent surgery during the year after an infusion of RTX for a total of 140 procedures including 94 orthopaedic surgeries (67%). Twelve complications (8.5% of procedures) occured in 9 patients (6.7%): 6 deep infections and 2 scars or superficial infections at the surgical site, 1 pulmonary infection, 1 delayed healing, 1 deep venous thrombosis and 1 death related to a septic shock. Infections at surgical site were reported for 5.7% of surgeries. The main characteristics of each group are detailed in the table. Spine surgery is associated with postoperativeAbstract : Background: The risk of post-surgical complications related to the use of non anti-TNF biological agents in patients with rheumatoid arthritis (RA) remains unclear. The aim of this study was to investigate the safety of surgery in RA patients treated by rituximab (RTX) in routine care using data from the AutoImmunity and Rituximab (AIR) registry. Methods: The AIR registry has been set up by the French Society of Rheumatology and includes RA patients treated with RTX. The charts of patients undergoing any surgery during the year following an infusion of RTX were reviewed in order to i)describe the frequency of postsurgical complications, ii) to compare the characteristics of patients w/o complications and iii) to identify the parameters associated with postoperative side effects in a multivariate logistic regression analysis. Results: 1972 patients have been enrolled patients until August 2010. 133 patients underwent surgery during the year after an infusion of RTX for a total of 140 procedures including 94 orthopaedic surgeries (67%). Twelve complications (8.5% of procedures) occured in 9 patients (6.7%): 6 deep infections and 2 scars or superficial infections at the surgical site, 1 pulmonary infection, 1 delayed healing, 1 deep venous thrombosis and 1 death related to a septic shock. Infections at surgical site were reported for 5.7% of surgeries. The main characteristics of each group are detailed in the table. Spine surgery is associated with postoperative complications in univariate analysis (p=0.048) with 2 reported spondylodiscitis but none were proven by a biopsy. In a multivariate logistic regression analysis, no predictive factors were identified. Conclusions: The occurrence of post-surgical complications in 6.7% of RA patients receiving RTX is similar with those reported with TNF alpha blockers (between 0 and 12.5%). No risk factor of complications was identified. Disclosure of Interest: None Declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 71(2012)Supplement 3
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 71(2012)Supplement 3
- Issue Display:
- Volume 71, Issue 3 (2012)
- Year:
- 2012
- Volume:
- 71
- Issue:
- 3
- Issue Sort Value:
- 2012-0071-0003-0000
- Page Start:
- 196
- Page End:
- 196
- Publication Date:
- 2014-01-23
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2012-eular.2087 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18220.xml